Bank of America
SANA icon

Bank of America’s Sana Biotechnology SANA Stock Holding History

Bank of America’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.1M Buy
5,748,454
+2,801,593
+95% +$9.03M ﹤0.01% 2484
2026
Q1 		$8.49M Buy
2,946,861
+1,760,610
+148% +$6.93M ﹤0.01% 3090
2025
Q4 		$4.83M Buy
1,186,251
+268,609
+29% +$1.2M ﹤0.01% 3425
2025
Q3 		$3.26M Buy
917,642
+32,814
+4% +$119K ﹤0.01% 4399
2025
Q2 		$2.42M Buy
884,828
+355,976
+67% +$734K ﹤0.01% 4608
2025
Q1 		$888K Sell
528,852
-602,961
-53% -$1.69M ﹤0.01% 5305
2024
Q4 		$1.84M Buy
1,131,813
+115,347
+11% +$344K ﹤0.01% 4518
2024
Q3 		$4.23M Buy
1,016,466
+106,299
+12% +$558K ﹤0.01% 3898
2024
Q2 		$4.97M Buy
910,167
+362,140
+66% +$2.89M ﹤0.01% 3627
2024
Q1 		$5.48M Buy
548,027
+66,237
+14% +$496K ﹤0.01% 3527
2023
Q4 		$1.97M Buy
481,790
+79,396
+20% +$292K ﹤0.01% 4422
2023
Q3 		$1.56M Buy
402,394
+23,153
+6% +$124K ﹤0.01% 4485
2023
Q2 		$2.26M Sell
379,241
-303,190
-44% -$1.75M ﹤0.01% 4113
2023
Q1 		$2.23M Buy
682,431
+14,849
+2% +$59.3K ﹤0.01% 4255
2022
Q4 		$2.64M Buy
667,582
+208,968
+46% +$1.02M ﹤0.01% 4003
2022
Q3 		$2.75M Buy
458,614
+93,915
+26% +$678K ﹤0.01% 3992
2022
Q2 		$2.35M Sell
364,699
-14,888
-4% -$94.8K ﹤0.01% 4164
2022
Q1 		$3.13M Buy
379,587
+324,866
+594% +$2.63M ﹤0.01% 4127
2021
Q4 		$847K Buy
54,721
+43,461
+386% +$838K ﹤0.01% 5441
2021
Q3 		$254K Sell
11,260
-1,008
-8% -$21.2K ﹤0.01% 6139
2021
Q2 		$241K Buy
12,268
+3,629
+42% +$82.2K ﹤0.01% 5972
2021
Q1 		$289K Buy
+8,639
New +$281K ﹤0.01% 5776

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Bank of America's SANA Position: Q2 2026 in Review

Bank of America increased its Sana Biotechnology (SANA) stake by 95% in Q2 2026, buying an estimated $9.03M and bringing the position to 5,748,454 shares worth $20.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2484.

Bank of America first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Bank of America held 5,748,454 shares of Sana Biotechnology worth $20.1M as of Q2 2026.
  • Bank of America bought 2,801,593 Sana Biotechnology shares in Q2 2026, an estimated $9.03M.
  • Sana Biotechnology made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #2484 holding.
  • Bank of America first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.